Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Total Bond Market Index Fund ETF (BND) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Vanguard Total Bond Market Index Fund ETFTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Vanguard Total Bond Market Index Fund ETF vs Intuitive Surgical, Inc. — how do they compare? Vanguard Total Bond Market Index Fund ETF trades at $72.33, while Intuitive Surgical, Inc. trades at $400.53 (market cap $141.75B). The key difference: Intuitive Surgical, Inc. is trading nearer its 52-week high, Vanguard Total Bond Market Index Fund ETF nearer its low. Which is the better fit depends on your goals.

BNDISRG
52-Week High
$75.17$592.85
52-Week Low
$72.15$332.02
Market Cap
$141.75B
Sector
Health
Enterprise Value
$136.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Total Bond Market Index Fund ETF

BND trades at $72.36, up 0.29% today, amid a bearish technical outlook with moving averages signaling sell pressure and oscillators neutral. The ETF shows consistent dividend distributions, with recent payouts of $0.25 and $0.24. News highlights institutional activity, including Boston Standard Wealth reducing its stake by 30.6% in Q2 2026 (SEC filing, 2026-08-05), while broader bond ETF inflows reached nearly $300 billion in H1 2026 (Zacks Investment Research, 2026-08-06).

The outlook remains cautious due to technical weakness and interest rate sensitivity, but BND offers income stability through dividends. Risks include Treasury yield volatility and inflation data impacts, yet it serves as a core fixed-income holding for diversification amid market uncertainty.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $393.38, up 3.85% on the day, with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. The stock exhibits premium valuation metrics, including a P/E of 46.01 and P/S of 13.08, supported by robust revenue growth, which reached $10.06B in 2025, and high net income margins of 28.45%. Recent news highlights analyst upgrades and optimism around the da Vinci 5 system's adoption.

The outlook remains positive given durable demand and innovation, but risks include heightened competition and valuation sensitivity. Wall Street consensus is bullish with a $518.10 price target, implying significant upside, though investors should weigh premium multiples against growth sustainability and competitive pressures in the medtech space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vanguard Total Bond Market Index Fund ETF

This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.

Read more on BND

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG